Clinical Case Study Compendium:

The impact of gilteritinib in daily practice as salvage treatment and as bridging therapy. Real-World Experiences by Dr. A. de Voeght...

Accessible only to healthcare professionals authorized to prescribe

Real-World Experiences by prof. dr. M. Beckers, UZ Leuven. Video of case report 5

Article part 2: The Role of Gilteritinib in the Treatment of Relapsed or Refractory FLT3-Mutated AML¹

Casus 3: Gilteritinib after intensive chemotherapy
Casus 4: Gilteritinib following an allogene hematopoïetic stem cell transplantation (allo-HSCT²)

Intended for: practitioners hematology
When: read now
Language: English
Duration: 10 minutes

1: Acute Myeloid Leukemia; 2: Hematopoietic Stem Cell Transplantation

MAT-BE-XOS-2026-00004 JAN 2026

AML: Acute Myeloid Leukemia